DE60135845D1 - Pralmorelin-haltige nasentropfen-präparate - Google Patents
Pralmorelin-haltige nasentropfen-präparateInfo
- Publication number
- DE60135845D1 DE60135845D1 DE60135845T DE60135845T DE60135845D1 DE 60135845 D1 DE60135845 D1 DE 60135845D1 DE 60135845 T DE60135845 T DE 60135845T DE 60135845 T DE60135845 T DE 60135845T DE 60135845 D1 DE60135845 D1 DE 60135845D1
- Authority
- DE
- Germany
- Prior art keywords
- pralmorelin
- alanyl
- preparation
- nose drop
- drop preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Otolaryngology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000158676A JP3498041B2 (ja) | 2000-05-29 | 2000-05-29 | プラルモレリン含有点鼻用製剤 |
PCT/JP2001/004503 WO2001091782A1 (fr) | 2000-05-29 | 2001-05-29 | Preparations de gouttes nasales contenant de la pralmoreline |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60135845D1 true DE60135845D1 (de) | 2008-10-30 |
Family
ID=18663108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60135845T Expired - Fee Related DE60135845D1 (de) | 2000-05-29 | 2001-05-29 | Pralmorelin-haltige nasentropfen-präparate |
Country Status (7)
Country | Link |
---|---|
US (1) | US7008927B2 (de) |
EP (1) | EP1297838B1 (de) |
JP (1) | JP3498041B2 (de) |
AT (1) | ATE408413T1 (de) |
AU (1) | AU2001258859A1 (de) |
DE (1) | DE60135845D1 (de) |
WO (1) | WO2001091782A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7759312B2 (en) * | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
EP1888043A4 (de) * | 2005-03-11 | 2010-07-28 | Endo Pharmaceuticals Solutions | Octreotid-formulierungen mit kontrollierter freisetzung |
AU2007340158A1 (en) * | 2006-12-29 | 2008-07-10 | Revance Therapeutics, Inc. | Transport molecules using reverse sequence HIV-TAT polypeptides |
JP5622725B2 (ja) * | 2008-06-25 | 2014-11-12 | エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド.Endo Pharmaceuticals Solutionsinc. | エキセナチド及び他のポリペプチド類の持続的送達 |
AU2009262263B2 (en) * | 2008-06-25 | 2014-08-14 | Endo Pharmaceuticals Solutions Inc. | Octreotide implant having a release agent |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0080879B1 (de) * | 1981-11-28 | 1986-10-01 | Sunstar Kabushiki Kaisha | Stabilisiertes Interferon enthaltende pharmazeutische Zusammensetzung |
JPS63303931A (ja) | 1987-06-05 | 1988-12-12 | Sumitomo Pharmaceut Co Ltd | 経鼻投与用成長ホルモン放出活性物質製剤 |
IT1222395B (it) | 1987-07-30 | 1990-09-05 | Pierrel Spa | Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare |
JP3179538B2 (ja) | 1990-12-11 | 2001-06-25 | ノバルティス アクチエンゲゼルシャフト | 安定なヒトカルシトニンの水性溶液 |
US5663146A (en) * | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
DE69430132T2 (de) * | 1993-10-21 | 2002-08-29 | Hisamitsu Pharmaceutical Co., Inc. | Pernasale zusammensetzung und diese enthaltende pernasale zubereitung |
JP2660484B2 (ja) * | 1994-04-12 | 1997-10-08 | 株式会社ミドリ十字 | ヒト尿性トリプシンインヒビター含有液状製剤 |
JPH1045619A (ja) * | 1996-07-31 | 1998-02-17 | Kaken Pharmaceut Co Ltd | 成長ホルモン分泌促進ペプチド含有経口製剤 |
US5932548A (en) | 1998-06-03 | 1999-08-03 | Deghenghi; Romano | Lysine containing peptides for treatment of heart disease |
CA2413252A1 (en) * | 2000-06-23 | 2002-12-20 | Takahiko Murata | Preventives or remedies for heart failure |
JP2002053489A (ja) * | 2000-08-07 | 2002-02-19 | Kaken Pharmaceut Co Ltd | 筋肉増強剤・筋肉減衰の予防・治療剤 |
-
2000
- 2000-05-29 JP JP2000158676A patent/JP3498041B2/ja not_active Expired - Fee Related
-
2001
- 2001-05-29 WO PCT/JP2001/004503 patent/WO2001091782A1/ja active IP Right Grant
- 2001-05-29 AU AU2001258859A patent/AU2001258859A1/en not_active Abandoned
- 2001-05-29 AT AT01932322T patent/ATE408413T1/de not_active IP Right Cessation
- 2001-05-29 DE DE60135845T patent/DE60135845D1/de not_active Expired - Fee Related
- 2001-05-29 EP EP01932322A patent/EP1297838B1/de not_active Expired - Lifetime
- 2001-05-29 US US10/296,791 patent/US7008927B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7008927B2 (en) | 2006-03-07 |
US20030139347A1 (en) | 2003-07-24 |
AU2001258859A1 (en) | 2001-12-11 |
EP1297838A4 (de) | 2003-07-09 |
EP1297838A1 (de) | 2003-04-02 |
ATE408413T1 (de) | 2008-10-15 |
EP1297838B1 (de) | 2008-09-17 |
WO2001091782A1 (fr) | 2001-12-06 |
JP3498041B2 (ja) | 2004-02-16 |
JP2001335508A (ja) | 2001-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
DK1091729T3 (da) | Mikropartikelformulering til inhalation | |
DK1317419T3 (da) | Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler | |
ITMI912024A1 (it) | Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac. | |
CA2301017A1 (en) | Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds | |
SE8804629D0 (sv) | New therapeutically active compounds | |
WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
HRP20020404B1 (en) | Solutions containing epinastine | |
PL357132A1 (en) | Stable, nasally, orally or sublingually applicable pharmaceutical preparation | |
ATE455539T1 (de) | Darreichungsformen mit verlängerter wirkstofffreisetzung | |
DK1228758T3 (da) | Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom | |
SE0002476D0 (sv) | New compounds | |
DE60135845D1 (de) | Pralmorelin-haltige nasentropfen-präparate | |
NO912414L (no) | Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling. | |
WO2001051028A3 (en) | Formulations and methods for administration of pharmacologically or biologically active compounds | |
EP0647616A4 (de) | Zink-tranexamat derivat. | |
ATE291421T1 (de) | Pharmazeutische, ramipril enthaltende brauseformulierung | |
CA2406179A1 (en) | Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors | |
DK1220678T3 (da) | Farmaceutiske præparater indeholdende kobber, salicylsyre og C-vitamin | |
AR026631A1 (es) | ''3-4-dihidroquinazolinas 5,6-disustituidas'' | |
SE9900177L (sv) | Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus | |
GT199900171A (es) | Concentrado oral de sertralina. | |
TR200302027T4 (tr) | Hayvanlarda görülen parazit kaynaklı hastalıkarın tedavisine yönelik ilaç kompozisyonları | |
WO2001045727A3 (en) | Stabilized veterinary compositions comprising more than one antiviral agent | |
NO20032035D0 (no) | Terapeutiske midler for heratokonjunktivitis sykdommer omfattende farnesyleddiksyre som aktiv ingrediens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |